CC
CDLX icon

Caxton Corporation’s Cardlytics CDLX Stock Holding History

Caxton Corporation’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-854
Closed -$470K – 19
2022
Q1 		$470K Sell
854
-20
-2% -$12.1K 0.58% 29
2021
Q4 		$578K Buy
874
+194
+29% +$148K 0.47% 40
2021
Q3 		$571K Sell
680
-1
-0.1% -$1.01K 0.46% 40
2021
Q2 		$864K Buy
681
+302
+80% +$341K 0.59% 21
2021
Q1 		$416K Buy
379
+92
+32% +$121K 0.27% 36
2020
Q4 		$410K Buy
+287
New +$306K 0.26% 22
2020
Q1 		– Sell
-559
Closed -$352K – 21
2019
Q4 		$352K Buy
+559
New +$273K 0.34% 15

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Caxton Corporation's CDLX Position: Q2 2022 in Review

Caxton Corporation sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 854 shares — an estimated $470K sold.

Caxton Corporation first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $864K in Q2 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Caxton Corporation reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Caxton Corporation sold 854 Cardlytics shares in Q2 2022, an estimated $470K.
  • Caxton Corporation first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
  • Caxton Corporation's Cardlytics position peaked at $864K in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Caxton Corporation's 13F filing for Q2 2022, filed 15 Aug 2022.